LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Articles

1 FTSE 100 stock I’d buy in April, and 1 I’d avoid

I'd rate these two as one of the best and one of the worst in the FTSE 100 (INDEXFTSE:UKX).

Read more »

Investing Articles

2 Neil Woodford stocks I’d buy in an instant

These two Neil Woodford stocks could deliver high returns.

Read more »

Investing Articles

Is this top FTSE 100 income stock a clear takeover candidate?

Could this company find itself a takeover target once again?

Read more »

Investing Articles

These 2 bargain dividend stocks could beat the FTSE 100 in 2017

Improving financial performance could allow these two stocks to outperform the FTSE 100 (INDEXFTSE:UKX).

Read more »

Investing Articles

Now Neil Woodford owns just eight FTSE stocks!

Renowned blue-chip master Neil Woodford now owns just eight FTSE 100 (INDEXFTSE: UKX) stocks.

Read more »

Investing Articles

2 dependable shares to retire on

Bilaal Mohamed reveals two perfect picks for long-term income investors.

Read more »

Investing Articles

Will this spin-off stock continue to slay FTSE 100 giants?

Roland Head asks if this potential FTSE 100 (INDEXFTSE:UKX) giant killer is worth the risk.

Read more »

Investing Articles

3 FTSE 100 stocks I’d never sell

There are some FTSE 100 (INDEXFTSE:UKX) shares that really do deserve to be held forever.

Read more »

Investing Articles

Is this the FTSE 100’s top growth stock?

This FTSE 100 (INDEXFTSE: UKX) unsung hero good could be a top growth pick, says G A Chester.

Read more »

Investing Articles

3 great income stocks I’d buy today

If you are looking for a base rate busting income these three FTSE 100 companies are a great place to…

Read more »

Investing Articles

A FTSE 100 giant with 20% upside to consider

This blue chip could have a possible upside of 20%.

Read more »

Investing Articles

Are shares in GlaxoSmithKline plc now in bargain territory?

Paul Summers casts his eyes over today's results from pharmaceutical giant GlaxoSmithKline plc (LON:GSK).

Read more »